• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病中的免疫异常与内皮细胞损伤

Immunological abnormalities and endothelial cell injury in Kawasaki disease.

作者信息

Nonoyama S

机构信息

Department of Pediatrics, Faculty of Medicine, Tokyo Medical and Dental University.

出版信息

Acta Paediatr Jpn. 1991 Dec;33(6):752-5. doi: 10.1111/j.1442-200x.1991.tb02604.x.

DOI:10.1111/j.1442-200x.1991.tb02604.x
PMID:1801555
Abstract

Kawasaki disease is an acute febrile disease causing vasculitis, which may lead to as severe a complication as myocardial infarction. This disease is characterized by marked activation of the immune system, including elevation of various cytokines, polyclonal B cell activation, and decrease of CD8+ cells. The high levels of cytokines induce adhesion molecules and a new antigen on endothelial cells. As a result, the immune cells bind to the endothelium and the activated immune cells produce cytotoxic antibodies against the new antigen on the endothelial cells. Thus, the activated immune system is involved in the endothelial cell injury. IVIG (intravenous immunoglobulin) therapy suppresses the activated immune system and reduces the endothelial cell damage.

摘要

川崎病是一种引起血管炎的急性发热性疾病,可能导致如心肌梗死这样严重的并发症。这种疾病的特征是免疫系统显著激活,包括各种细胞因子升高、多克隆B细胞激活以及CD8+细胞减少。高水平的细胞因子诱导内皮细胞上的黏附分子和一种新抗原。结果,免疫细胞与内皮细胞结合,活化的免疫细胞产生针对内皮细胞上新抗原的细胞毒性抗体。因此,活化的免疫系统参与了内皮细胞损伤。静脉注射免疫球蛋白(IVIG)疗法可抑制活化的免疫系统并减少内皮细胞损伤。

相似文献

1
Immunological abnormalities and endothelial cell injury in Kawasaki disease.川崎病中的免疫异常与内皮细胞损伤
Acta Paediatr Jpn. 1991 Dec;33(6):752-5. doi: 10.1111/j.1442-200x.1991.tb02604.x.
2
The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease.细胞因子介导的血管内皮激活在川崎病发病机制中的潜在作用。
Acta Paediatr Jpn. 1991 Dec;33(6):739-44. doi: 10.1111/j.1442-200x.1991.tb02602.x.
3
Immunomodulation by intravenous immune globulin in Kawasaki disease.
J Allergy Clin Immunol. 1989 Oct;84(4 Pt 2):588-93; discussion 593-4. doi: 10.1016/0091-6749(89)90195-4.
4
Clinical and immunologic aspects of Kawasaki disease.川崎病的临床与免疫学方面
Immunodefic Rev. 1989;1(3):261-71.
5
Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.单核细胞衍生的白细胞介素-1β作为 S100A12 诱导的人冠状动脉内皮细胞无菌性炎症激活的驱动因素:对川崎病发病机制的影响。
Arthritis Rheumatol. 2019 May;71(5):792-804. doi: 10.1002/art.40784. Epub 2019 Mar 25.
6
Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.瑞典川崎病患儿的炎症参数和可溶性细胞黏附分子:与心脏病变及静脉注射免疫球蛋白治疗的关系
Acta Paediatr. 1999 Aug;88(8):844-8. doi: 10.1080/08035259950168766.
7
The immunologic effects of IVIG in Kawasaki disease.静脉注射免疫球蛋白在川崎病中的免疫作用。
Int Rev Immunol. 1989;5(2):197-202. doi: 10.3109/08830188909061987.
8
Kawasaki disease: pathophysiology and insights from mouse models.川崎病:病理生理学和来自小鼠模型的见解。
Nat Rev Rheumatol. 2020 Jul;16(7):391-405. doi: 10.1038/s41584-020-0426-0. Epub 2020 May 26.
9
[Cytokines in Kawasaki disease].[川崎病中的细胞因子]
Nihon Rinsho. 2014 Sep;72(9):1548-53.
10
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.内皮细胞活化及高白细胞介素-1分泌在急性川崎病发病机制中的作用
Lancet. 1989 Dec 2;2(8675):1298-302. doi: 10.1016/s0140-6736(89)91910-7.

引用本文的文献

1
Platelet-derived microRNA-223 attenuates TNF-α induced monocytes adhesion to arterial endothelium by targeting ICAM-1 in Kawasaki disease.血小板衍生的 microRNA-223 通过靶向 ICAM-1 减轻川崎病 TNF-α 诱导的单核细胞黏附至动脉内皮。
Front Immunol. 2022 Aug 2;13:922868. doi: 10.3389/fimmu.2022.922868. eCollection 2022.
2
A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.与川崎病相关的冠状病毒综述:对与COVID-19相关的多系统炎症综合征发病机制的可能影响
Clin Med Insights Pediatr. 2022 Feb 16;16:11795565221075319. doi: 10.1177/11795565221075319. eCollection 2022.
3
Differential expression of long non-coding RNAs SRA, HCG22 and MHRT in children with Kawasaki disease.
川崎病患儿中长链非编码RNA SRA、HCG22和MHRT的差异表达
Exp Ther Med. 2021 Sep;22(3):1022. doi: 10.3892/etm.2021.10454. Epub 2021 Jul 15.
4
The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway.可溶性环氧化物水解酶抑制剂和14,15-环氧二十碳三烯酸通过PPARγ/STAT1信号通路对川崎病的抗炎作用
Front Pediatr. 2020 Aug 12;8:451. doi: 10.3389/fped.2020.00451. eCollection 2020.
5
Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.人类冠状病毒229E而非NL63感染可能与川崎病有关。
J Med Virol. 2014 Dec;86(12):2146-53. doi: 10.1002/jmv.23950. Epub 2014 Apr 24.
6
Alteration of CD4CD25Foxp3 T cell level in Kawasaki disease.川崎病中CD4CD25Foxp3 T细胞水平的改变。
Korean J Pediatr. 2011 Apr;54(4):157-62. doi: 10.3345/kjp.2011.54.4.157. Epub 2011 Apr 30.
7
Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.印度北部一组儿童川崎病急性期后自身抗体谱的研究。
Rheumatol Int. 2006 Jun;26(8):693-6. doi: 10.1007/s00296-005-0050-y. Epub 2005 Nov 25.
8
Cardiac sequelae of Kawasaki disease among recurrent cases.川崎病复发病例的心脏后遗症。
Arch Dis Child. 1998 Feb;78(2):163-5. doi: 10.1136/adc.78.2.163.